According to Acumen Research and Consulting, the global orthopedic biomaterials market size is expected to reach around US$ 26 billion by 2026 growing at noteworthy CAGR around 10.0 % throughout the forecast period 2019 to 2026.
Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For many orthopedic apps, biomaterial systems are frequently referred to as' Implants.' These biomaterials assist to restore the structural integrity of the bone damaged by trauma or diseases. Prior to its use in orthopedic apps, the biocompatibility of the material is the main factor to consider. The selection of material, the suitable structure, the stabilization and several properties, such as hardness, depend on the achievement of biomaterials in biological applications.
The report provides analysis of global Orthopedic Biomaterials market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
The world market for orthopedic biomaterials is largely influenced by the growing population of elderly patients, increasing surgeries, different public support, as well as improving young people's knowledge of health. The continuing study into biomaterial growth and its wider range of applications are one of the key drivers for this industry. Additional driving variables for the orthopedic biomaterials market include increased investment in new growth, public financing and grant initiative, technological advancement, and increased senior citizenship. Long-term information for clinical trials, rigorous regulatory legislation, post-implantation problems such as fracture fatigue and diciy reimbursement policies are the main disruptive factors that curtail market growth.
Increased incidence of musculoskeletal disorders and chronic skeletal disorders increases product demand and thus increases market growth. The growing geriatric population is anticipated to increase the demand further. This is extremely prone to these circumstances.
For example, as in the United States the Census Bureau, aged 65 and older, has grown by 1,6 million between 2014 and 2015. Another factor that drives increasing demand for orthopedic biomaterials is the increase in trauma instances resulting from accidents, fall and sport. The risk of accidents increases as more and more individuals engage in sports and leisure operations.
In 2016, approximately 213 million Americans aged 6 years and older, for exemple, were involved in sports and fitness operations in 2015, up from 209 million in 2014, according to National Health Statistical Reports. The development of this industry is also stepped up by the increasing amount of orthopedic surgeries such as joint arthroplasty. In addition, the development of the industry globally has been strengthened by the increased demand for the next generation orthopedic biomaterials tailored to satisfy the needs of a specific orthopedic procedure. On the other side, restricted coverage choices for reimbursement of orthopedic implants in several nations combined with decreasing reimbursement prevented market development. Further, a failure to reimburse producers has pressured them to reduce the prices for these products, which have reduced market growth.
Material Type Stance
Due to an increase in ceramic acceptance in the repair of difficult tissues in multiple processes, the Ceramics & Bioactive Glass segment resulted the market in 2018. On the other side, due to the comprehensive use of polymers as bone cements and cargo-bearing superficials for complete joint arthroplasties, the Polymer Segment is expected to be the fastest CAGR between 2019 and 2026. Moreover, the demand for polymers worldwide has risen with sophisticated polymers and biopolymers available for multiple applications such as orthobiological tissue fixation and bio-resorbable tissue fixation.
The dominant segment arose from orthopedic implants in 2018 and its dominance is anticipated to remain in the forecast period. The increased incidences of disks and bone fractures in this sector and growing cases of trauma are anticipated to increase the demand for products. Due to the growing amount of bone repair and rebuilding operations around the world as a consequence of an increase of obesity and trauma, the orthhobiologics segment should be recording a rapid CAGR of about 10.5% over the forecast era. The figures released by the WHO state that approximately 1,3 million individuals are killed every year owing to traffic accidents worldwide and 93% of the total road deaths happen in middle and low income nations.
In 2018, North America dominated the market and is expected to further grow over the forecast period in a profitable CAGR. This increase is attributable to the increase in patients who require knee replacement, rehabilitation and other orthopedic procedures related to joint. The fast adoption of state-of - the-art products for bone void filling and implant load bearing is expected to further push the regional market. In addition, an increased awareness amongst the population of biodegradable products, increasing health care costs as well as the increasing demand for sophisticated technological treatments and products and increased public support are expected to increase the development of North American market for orthopedic biomaterials. For example, in the United States in 2016, about 1,61,040 joint replacement procedures were reported under the American Joint Substitution Registry.
Europe is the second biggest and strongest market for orthopedic biomaterials worldwide. Due to the accessibility of innovative therapy equipment and the increasing study activities in nanotechnological orthopedic biomaterials, the European market is anticipated to expand over the forecast era. Furthermore, the development of the orthopedic biomaterials market is being driven by growing instances of orthopedic surgery and increased public health consciousness.
In a CAGR of around 11.5%, Asia Pacific is anticipated in the prediction era to be the fastest growth regional market. Increasing incidence of bone-degenerative and bone disorders in low and middle income nations are key factors driving the regional market. In addition, the constant increase in medical spending and improvement in health-care infrastructure are anticipated to drive the market in this region highly.
In the Middle East and Africa, there are some important variables such as absence of knowledge, restricted access and accessibility of therapies which are supposed to demonstrate the lowest development. Due to increasing health expenses and the general development of the health-care situation, the United Arab Emirates is also the main market in the Middle East.
Global Orthopedic Biomaterials Market, By Material Type
Global Orthopedic Biomaterials Market, By Application
Global Orthopedic Biomaterials Market, By Geography
The market research study on “Orthopedic Biomaterials Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Orthopedic Biomaterials market segments with market dynamics and their impact. The report also covers basic technology development policies.
It offers an assessment of the recent industry trends for each sub-segment between 2015 and 2026, and anticipates income development at worldwide, regional and nation levels. For this research, on the grounds of the type, application, and region ARC segmenteted the worldwide Orthopedic Biomaterials market report:
Key Players & Strategies
With a few smaller respondents, the worldwide sector is oligopolistic in nature. Some vital companies operating in this market include DePuy Synthes Inc., DSM Biomedical, Stryker Corp., Invibio Ltd., AdvanSource Biomaterials Corp., Zimmer Biomet, Globus Medical, Matexcel, Exactech, Inc., CAM Bioceramics B.V., Evonik Industries AG, and Heraeus Holding.
Growing population of elderly patients, increasing surgeries, different public support, as well as improving young people's knowledge of health are main driver of the orthopedic biomaterials market.
Factors such increased incidence of musculoskeletal disorders and chronic skeletal disorders increases product demand restrain the orthopedic biomaterials market growth.
According to the Acumen Research and Consulting, the orthopedic biomaterials market value is anticipated to be hit around US$ 26 billion in 2026.
The orthopedic biomaterials market is anticipated to grow over 10% CAGR during the forecast period 2019 to 2026.
In a CAGR of around 11.5%, Asia Pacific is anticipated in the prediction era to be the fastest growth regional market.
DePuy Synthes Inc., DSM Biomedical, Stryker Corp., Invibio Ltd., AdvanSource Biomaterials Corp., Zimmer Biomet, Globus Medical, Matexcel, Exactech, Inc., CAM Bioceramics B.V., Evonik Industries AG, and Heraeus Holding are the top players operating in the orthopedic biomaterials market.